These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1042 related items for PubMed ID: 28982370

  • 1. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
    Tai C, Gan T, Zou L, Sun Y, Zhang Y, Chen W, Li J, Zhang J, Xu Y, Lu H, Xu D.
    BMC Cardiovasc Disord; 2017 Oct 05; 17(1):257. PubMed ID: 28982370
    [Abstract] [Full Text] [Related]

  • 2. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J, Zhang W, Zhang X, Han F, Li X, He X, Li Q, Chen J.
    JAMA Intern Med; 2014 May 05; 174(5):773-85. PubMed ID: 24687000
    [Abstract] [Full Text] [Related]

  • 3. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N, Manoharan K, Davies C, Lumbers RT.
    Cochrane Database Syst Rev; 2021 May 22; 5(5):CD012721. PubMed ID: 34022072
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials.
    Bangalore S, Fakheri R, Toklu B, Ogedegbe G, Weintraub H, Messerli FH.
    Mayo Clin Proc; 2016 Jan 22; 91(1):51-60. PubMed ID: 26763511
    [Abstract] [Full Text] [Related]

  • 5. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
    Turgeon RD, Kolber MR, Loewen P, Ellis U, McCormack JP.
    PLoS One; 2019 Jan 22; 14(2):e0212907. PubMed ID: 30817783
    [Abstract] [Full Text] [Related]

  • 6. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.
    Zou Z, Yuan HB, Yang B, Xu F, Chen XY, Liu GJ, Shi XY.
    Cochrane Database Syst Rev; 2016 Jan 27; 2016(1):CD009210. PubMed ID: 26816003
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials.
    Jong P, Demers C, McKelvie RS, Liu PP.
    J Am Coll Cardiol; 2002 Feb 06; 39(3):463-70. PubMed ID: 11823085
    [Abstract] [Full Text] [Related]

  • 8. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.
    Liu Y, Ma X, Zheng J, Jia J, Yan T.
    BMC Nephrol; 2017 Jun 30; 18(1):206. PubMed ID: 28666408
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in hypertensive patients with myocardial infarction or heart failure: a systematic review and meta-analysis.
    Ohtsubo T, Shibata R, Kai H, Okamoto R, Kumagai E, Kawano H, Fujiwara A, Kitazono T, Murohara T, Arima H.
    Hypertens Res; 2019 May 30; 42(5):641-649. PubMed ID: 30948834
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin receptor blockers for heart failure.
    Heran BS, Musini VM, Bassett K, Taylor RS, Wright JM.
    Cochrane Database Syst Rev; 2012 Apr 18; 2012(4):CD003040. PubMed ID: 22513909
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
    Hoang V, Alam M, Addison D, Macedo F, Virani S, Birnbaum Y.
    Cardiovasc Drugs Ther; 2016 Apr 18; 30(2):189-98. PubMed ID: 26861251
    [Abstract] [Full Text] [Related]

  • 12. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.
    Driscoll A, Currey J, Tonkin A, Krum H.
    Cochrane Database Syst Rev; 2015 Dec 21; 2015(12):CD009889. PubMed ID: 26689943
    [Abstract] [Full Text] [Related]

  • 13. ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
    Ricci F, Di Castelnuovo A, Savarese G, Perrone Filardi P, De Caterina R.
    Int J Cardiol; 2016 Aug 15; 217():128-34. PubMed ID: 27179902
    [Abstract] [Full Text] [Related]

  • 14. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure.
    Savarese G, Costanzo P, Cleland JG, Vassallo E, Ruggiero D, Rosano G, Perrone-Filardi P.
    J Am Coll Cardiol; 2013 Jan 15; 61(2):131-42. PubMed ID: 23219304
    [Abstract] [Full Text] [Related]

  • 15. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y, He D, Zhang W, Xing Y, Guo Y, Wang F, Jia J, Yan T, Liu Y, Lin S.
    Drugs; 2020 Jun 15; 80(8):797-811. PubMed ID: 32333236
    [Abstract] [Full Text] [Related]

  • 16. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, Zhao N, Liu L, Lv J, Zhang H, Wang H.
    Am J Kidney Dis; 2016 May 15; 67(5):728-41. PubMed ID: 26597926
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG.
    J Indian Med Assoc; 2009 Mar 15; 107(3):178-82. PubMed ID: 19810392
    [Abstract] [Full Text] [Related]

  • 18. Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials.
    Kızılırmak P, Üresin Y, Özdemir O, Kılıçkıran Avcı B, Tokgözoğlu L, Öngen Z.
    Turk Kardiyol Dern Ars; 2017 Jan 15; 45(1):49-66. PubMed ID: 28106020
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC, Heran BS, Wright JM.
    Cochrane Database Syst Rev; 2014 Aug 22; 2014(8):CD009096. PubMed ID: 25148386
    [Abstract] [Full Text] [Related]

  • 20. Treatment with renin-angiotensin system inhibitors and prognosis of heart failure with preserved ejection fraction: A propensity-matched study in the community.
    Egido JJ, Gomez R, Romero SP, Andrey JL, Ramirez D, Rodriguez A, Pedrosa MJ, Gomez F.
    Int J Clin Pract; 2019 Jun 22; 73(6):e13317. PubMed ID: 30694579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.